Enanta Pharmaceuticals, Inc. announced the pricing of an upsized underwritten public offering of 6,500,000 shares of its common stock. The shares were priced at $10.00 per share.
All of the shares in the offering are being sold by Enanta, aiming to raise capital for its ongoing operations and pipeline development. The offering was expected to close on October 2, 2025, subject to the satisfaction of customary closing conditions.
This equity offering provides Enanta with additional financial resources but also results in dilution for existing shareholders. The upsized nature of the offering indicates strong demand for the shares, despite the dilutive effect.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.